Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
Today's Liberal News
By Zachary Brennan
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
Azar says states will decide who gets first Covid-19 shots
He and other top government officials have said that about 40 million doses of the vaccine will likely be available next month.
FDA grants emergency use of Covid treatment given to Trump
The treatment is not authorized for patients who are hospitalized due to the coronavirus or who require oxygen therapy.
AstraZeneca to seek FDA authorization for vaccine based on foreign trial data
It’s the third Covid-19 vaccine maker to report results from a late-stage trial.
FDA grants emergency use of Covid treatment given to Trump
The treatment is not authorized for patients who are hospitalized due to the coronavirus or who require oxygen therapy.
FDA grants emergency use of Covid treatment given to Trump
The treatment is not authorized for patients who are hospitalized due to the coronavirus or who require oxygen therapy.
Moderna close to revealing first data on whether its vaccine works
The news comes days after Pfizer revealed that initial data suggest its vaccine is more than 90 percent effective.
Moderna close to revealing first data on whether its vaccine works
The news comes days after Pfizer revealed that initial data suggest its vaccine is more than 90 percent effective.
Moderna close to revealing first data on whether its vaccine works
The news comes days after Pfizer revealed that initial data suggest its vaccine is more than 90 percent effective.
Moderna close to revealing first data on whether its vaccine works
The news comes days after Pfizer revealed that initial data suggest its vaccine is more than 90 percent effective.
FDA grants emergency authorization for Lilly antibody treatment
The drug, known as a monoclonal antibody, mimics the body’s natural defenses against the virus.
Moderna close to revealing first data on whether its vaccine works
The news comes days after Pfizer revealed that initial data suggest its vaccine is more than 90 percent effective.
FDA grants emergency authorization for Lilly antibody treatment
The drug, known as a monoclonal antibody, mimics the body’s natural defenses against the virus.
FDA grants emergency authorization for Lilly antibody treatment
The drug, known as a monoclonal antibody, mimics the body’s natural defenses against the virus.
Pfizer won’t seek coronavirus vaccine authorization until after election
The move by Pfizer continues the company’s push to publicly distance itself from the presidential race.